The Increasing Prevalence Of Osteoporosis Is Driving The Growth Of The Due To Its Impact On Bone Density And Fracture Risk Is Playing A Role In Shaping The mRNA Cancer Vaccines And Therapeutics Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The mRNA Cancer Vaccines And Therapeutics Market Compare Between 2026 And 2030?
The mrna cancer vaccines and therapeutics market size has experienced significant expansion in recent years. This market is set to expand from $71.22 billion in 2025 to $82.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.1%. The expansion observed in the past period is attributable to the triumphs of mrna platforms in infectious disease vaccines, progress in cancer immunology research, a deepening comprehension of tumor antigens, initial clinical validation of mrna cancer therapies, and increasing public and private investments in oncology innovation.
The mrna cancer vaccines and therapeutics market size is expected to undergo rapid expansion over the next few years. This market is projected to grow to $141.51 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.4%. The anticipated growth during this forecast period can be linked to the increasing global prevalence of cancer, the escalating need for personalized and targeted cancer treatments, an expansion in mrna manufacturing capabilities, a rise in oncology clinical trials utilizing mrna platforms, and strategic collaborations among biotech and pharmaceutical enterprises. Significant trends for the forecast timeframe include the increasing adoption of personalized cancer vaccines, the extension of mrna-based therapeutics beyond oncology applications, a heightened focus on developing neoantigen-specific vaccines, an enlarged clinical pipeline for mrna cancer immunotherapies, and greater investment in scalable mrna manufacturing platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
What Major Factors Are Driving The mRNA Cancer Vaccines And Therapeutics Market Forward?
The growing incidence of cancer is anticipated to fuel the expansion of the mRNA cancer vaccine and therapeutic market in the future. Cancer represents a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells, which can infiltrate and harm healthy tissues. This heightened occurrence of cancer is primarily linked to elements like inactive lifestyles, inadequate nutrition, and exposure to environmental contaminants, each contributing to an elevated risk for diverse forms of malignancy. mRNA cancer vaccines and therapeutics are pivotal in advancing cancer treatment, facilitating tailored, precise immune reactions that aid the body in more efficiently recognizing and eradicating cancer cells, consequently enhancing therapeutic results. As an illustration, in January 2024, data from the American Cancer Society, Inc., a US-based cancer advocacy organization, projects that the United States will experience over 611,000 cancer-related deaths in 2024, equating to more than 1,600 fatalities daily. Consequently, the expanding prevalence of cancer is propelling the growth of the mRNA cancer vaccine and therapeutic market.
How Is The mRNA Cancer Vaccines And Therapeutics Market Categorized Across Its Segment Groups?
The mrna cancer vaccines and therapeutics market covered in this report is segmented –
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
What Trends Are Affecting The Growth Of The mRNA Cancer Vaccines And Therapeutics Market?
Major companies operating in the mRNA cancer vaccines and therapeutics market are focusing on developing innovative solutions, such as personalized neoantigen vaccines, to enhance immune response and improve survival outcomes in cancer patients. Personalized neoantigen vaccines are cancer therapies designed for each patient, utilizing unique tumor-specific mutations to stimulate the immune system to target and destroy cancer cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, partnered with Moderna Therapeutics, Inc., a US-based biotechnology company, to initiate a Phase 3 randomized clinical trial (V940-001) to evaluate mRNA-4157 (V940) in combination with KEYTRUDA (pembrolizumab) as an adjuvant treatment for patients with resected high-risk (Stage IIB-IV) melanoma. This study follows positive results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which showed a meaningful benefit of the combination over KEYTRUDA alone in reducing recurrence and distant metastasis risk. The Phase 3 trial aims to confirm these findings by assessing relapse-free survival and distant metastasis-free survival as primary and secondary endpoints, respectively.
Which Firms Are Influencing Competition In The mRNA Cancer Vaccines And Therapeutics Market?
Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)
Get The Full mRNA Cancer Vaccines And Therapeutics Market Report:
Which Region Dominates The mRNA Cancer Vaccines And Therapeutics Market By Market Share?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna cancer vaccines and therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized mRNA Cancer Vaccines And Therapeutics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global mRNA Cancer Vaccines And Therapeutics Market 2026, By The Business Research Company
Mrna Cancer Vaccines And Therapeutics Market Report 2026
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
